Adverse events of cold snare compared with hot snare and ablation endoscopic mucosal resection for large colorectal polyps
Unerwünschte Ereignisse von Cold Snare im Vergleich zu Hot Snare und ablativer endoskopischer Mukosaresektion bei großen kolorektalen Polypen
Endoscopy · 01.02.2026 · 58 (02) · 163-173
DOI: 10.1055/a-2665-0521 ↗Auf einen Blick
Bei 1.762 Patient:innen mit großen kolorektalen Polypen traten schwere unerwünschte Ereignisse unter Cold EMR seltener auf als unter Hot EMR. Auch schwere Blutungen und Perforationen waren numerisch seltener.
Fragestellung
Wie unterscheiden sich unerwünschte Ereignisse bei Cold EMR im Vergleich zu Hot EMR bei großen nicht gestielten kolorektalen Polypen?
Methode
Sekundäranalyse von vier prospektiven multizentrischen Studien mit konsekutiven Patient:innen, die von 2019 bis 2024 eine EMR erhielten.
Ergebnisse
1762 Patient:innen; 522 Cold EMR und 1368 Hot EMR. Schwere AEs: 1,9 % vs. 4,7 %; schwere PEB: 1,3 % vs. 2,3 %; Perforation: 0,2 % vs. 1,2 %.
Schlussfolgerung der Autor:innen
Cold EMR zeigte niedrigere Raten schwerer AEs, schwerer PEB und Perforation als Hot EMR. Perforation und Mortalität traten fast ausschließlich nach Hot EMR auf.
Kernaussagen
- Schwere AEs: 1,9 % bei Cold EMR vs. 4,7 % bei Hot EMR
- Schwere PEB und Perforation waren unter Cold EMR numerisch seltener
- Hot EMR mit/ohne Ablation erhöhte die SAEs nicht gegenüber Hot EMR ohne Ablation
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Vergleichsstudie in der Zeitschrift Endoscopy, erschienen am 01.02.2026. Verfasst von Edgard Medawar und 26 weiteren Autor:innen. Beteiligte Einrichtung: University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Colonic Polyps, Colonoscopy, Endoscopic Mucosal Resection, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Endoscopic mucosal resection (EMR) techniques for large (≥20 mm) nonpedunculated colorectal polyps (LNPCPs) have expanded with the introduction of ablation and cold EMR. This study assessed adverse events (AEs) for the newer EMR techniques, including cold EMR, compared with hot EMR. We conducted a secondary analysis of four prospective multicenter studies of consecutive patients with LNPCPs undergoing EMR from 2019 to 2024. The primary outcome was serious AEs (SAEs) with cold and hot EMR. Secondary outcomes included SAEs in the hot EMR subgroups (no ablation [hEMR], margin ablation [hEMR-m], margin and base ablation [hEMR-mb]). 1762 patients (mean age 65.8; 1890 LNPCPs) were included: 522 cold and 1368 hot EMRs (368 hEMR, 770 hEMR-m, 230 hEMR-mb). SAEs were higher with hot EMR (4.7%, 95%CI 3.6%–5.9%) vs. cold EMR (1.9%, 95%CI 0.9%–3.5%), also for the subgroups of hEMR (6.0%, 95%CI 3.8%–8.9%), hEMR-m (3.9%, 95%CI 2.6%–5.5%), and hEMR-mb (5.2%, 95%CI 2.7%–8.9%). Serious postendoscopic bleeding (PEB) was numerically higher with hot EMR (2.3%, 95%CI 1.6%–3.3%) vs. cold EMR (1.3%, 95%CI 0.5%–2.7%), also for the subgroups of hEMR (3.0%, 95%CI 1.5%–5.3%), hEMR-m (1.9%, 95%CI 1.1%–3.2%), and hEMR-mb (2.6%, 95%CI 1.0%–5.6%). Perforation, intraprocedural and post-procedural, was numerically higher with hot EMR (1.2%, 95%CI 0.7%–2.0%) vs. cold EMR (0.2%, 95%CI 0.0%–1.1%). hEMR-m and hEMR-mb with clipping had lower rates of serious and overall PEB than no clipping. Cold EMR demonstrated lower rates of SAEs, serious PEB, and perforation compared with hot EMR. Perforation and mortality occurred almost exclusively after hot EMR. Hot EMR with margin +/− base ablation did not increase SAEs compared with hot EMR without ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Ottawa, Ottawa, Ontario, Canada.
- Université de Montréal, Montreal, Québec, Canada.
- Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States.
- Indiana University School of Medicine, Indianapolis, Indiana, United States.
- Penn State Health Milton S Hershey Medical Center, Hershey, Pennsylvania, United States.
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States.
ORCID-Profile: Edgard Medawar, Douglas K Pleskow, Michael B Wallace, Neal C Shahidi, Roupen Djinbachian, Daniel von Renteln
Zitieren
APA
Medawar, E., Pohl, H., Rex, D. K., Levenick, J. M., Pleskow, D. K., Khashab, M. A., Moyer, M., Yang, D., Melson, J., Wallace, M. B., Mosko, J. D., Shahidi, N. C., Singh, A., Gavric, A., Djinbachian, R., Gordon, S. R., Ngamruengphong, S., Taunk, P., Barber, J., …, & Additional members of the Large Polyp Study Consortium (2026). Adverse events of cold snare compared with hot snare and ablation endoscopic mucosal resection for large colorectal polyps. Endoscopy, 58(02), 163-173. https://doi.org/10.1055/a-2665-0521
Vancouver
Medawar E, Pohl H, Rex DK, Levenick JM, Pleskow DK, Khashab MA, et al. Adverse events of cold snare compared with hot snare and ablation endoscopic mucosal resection for large colorectal polyps. Endoscopy. 2026;58(02):163-173. doi:10.1055/a-2665-0521
BibTeX
@article{Medawar2026,
author = {Medawar, Edgard and Pohl, Heiko and Rex, Douglas K and Levenick, John M and Pleskow, Douglas K and Khashab, Mouen A and Moyer, Matthew and Yang, Dennis and Melson, Joshua and Wallace, Michael B and Mosko, Jeffrey D and Shahidi, Neal C and Singh, Ajaypal and Gavric, Aleksandar and Djinbachian, Roupen and Gordon, Stuart R and Ngamruengphong, Saowanee and Taunk, Pushpak and Barber, Jeremy and Piraka, Cyrus and Elmunzer, Badih J and Aslanian, Harry R and Elatrache, Mazen and Zolotarevsky, Eugene and Rastogi, Amit and von Renteln, Daniel and Additional members of the Large Polyp Study Consortium, Additional members of the Large Polyp Study Consortium},
title = {Adverse events of cold snare compared with hot snare and ablation endoscopic mucosal resection for large colorectal polyps},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {02},
pages = {163--173},
doi = {10.1055/a-2665-0521}
}
EUVIMED